Edwards Lifesciences
579 hedge funds and large institutions have $12.2B invested in Edwards Lifesciences in 2015 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 196 increasing their positions, 209 reducing their positions, and 49 closing their positions.
59% more call options, than puts
Call options by funds: $93.4M | Put options by funds: $58.6M
14% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 49
1% more funds holding
Funds holding: 576 → 579 (+3)
6% less repeat investments, than reductions
Existing positions increased: 196 | Existing positions reduced: 209
6% less capital invested
Capital invested by funds: $13B → $12.2B (-$805M)
29% less funds holding in top 10
Funds holding in top 10: 14 → 10 (-4)
30.26% less ownership
Funds ownership: 509.04% → 478.78% (-30%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$252M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$174M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$116M |
| 4 |
HM
HealthCor Management
New York
|
+$115M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$63.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$688M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$488M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$201M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$103M |
| 5 |
Two Sigma Investments
New York
|
-$68.3M |
EW Hedge Fund Activity: Q2 2015 in Review
579 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2015, worth a combined $12.2B — down 6.2% from $13B a quarter earlier.
Buyers outnumbered sellers: 56 funds opened new EW positions and 49 closed out — a net gain of 7 holders — while 196 added to existing stakes and 209 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $252M. The largest seller was State Street, exiting entirely with an estimated $688M sold.
- 579 institutional investors held Edwards Lifesciences (EW) as of Q2 2015, up from 576 in Q1 2015.
- Funds reported $12.2B of Edwards Lifesciences stock for Q2 2015, down 6.2% quarter-over-quarter.
- 56 funds opened new Edwards Lifesciences positions in Q2 2015 and 49 closed out, a net change of +7 holders.
- The largest Edwards Lifesciences buyer in Q2 2015 was Wellington Management Group, an estimated $252M added.
- The largest Edwards Lifesciences seller in Q2 2015 was State Street, an estimated $688M sold.
Based on aggregated 13F filings for Q2 2015.